David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.89% |
| 2 | Technology | 10.04% |
| 3 | Healthcare | 9.38% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
CRA International
CRAI
$1.08B
| $944K | ﹤0.01% |
33,886
+42
| +0.1% | +$1.23K |
|
|
IMMU
2727
DELISTED
Immunomedics Inc
IMMU
| $943K | ﹤0.01% |
232,218
-26,760
| -10% | -$109K |
|
|
OCR
2728
PUT
DELISTED
OMNICARE INC
OCR
| $943K | ﹤0.01% |
+10,000
| New | +$892K |
|
2729
Customers Bancorp
CUBI
$2.64B
| $941K | ﹤0.01% |
34,979
+16,992
| +94% | +$434K |
|
2730
Madrigal Pharmaceuticals
MDGL
$11.8B
| $941K | ﹤0.01% |
12,057
+6,623
| +122% | +$556K |
|
|
TPCO
2731
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $941K | ﹤0.01% |
+60,567
| New | +$1.03M |
|
|
ALDR
2732
DELISTED
Alder Biopharmaceuticals
ALDR
| $939K | ﹤0.01% |
17,724
-53,734
| -75% | -$1.95M |
|
|
CVO
2733
DELISTED
Cenevo, Inc.
CVO
| $936K | ﹤0.01% |
55,178
+3,256
| +6% | +$59.2K |
|
2734
CALL
CSX Corp
CSX
$95.4B
| $934K | ﹤0.01% |
85,800
| – | – |
|
2735
PUT
American Tower
AMT
$83.2B
| $933K | ﹤0.01% |
10,000
| – | – |
|
2736
Canadian Solar
CSIQ
$970M
| $933K | ﹤0.01% |
32,630
+10,882
| +50% | +$373K |
|
2737
ANI Pharmaceuticals
ANIP
$1.74B
| $931K | ﹤0.01% |
15,000
-21,829
| -59% | -$1.3M |
|
|
XLRN
2738
DELISTED
Acceleron Pharma
XLRN
| $924K | ﹤0.01% |
29,190
+10,997
| +60% | +$355K |
|
2739
CALL
SM Energy
SM
$8.49B
| $922K | ﹤0.01% |
20,000
| – | – |
|
2740
Korn Ferry
KFY
$4.33B
| $921K | ﹤0.01% |
26,496
-4,311
| -14% | -$142K |
|
2741
PUT
Cleveland-Cliffs
CLF
$6.57B
| $920K | ﹤0.01% |
212,500
-162,500
| -43% | -$864K |
|
|
HSII
2742
DELISTED
Heidrick & Struggles
HSII
| $919K | ﹤0.01% |
35,246
+13,943
| +65% | +$349K |
|
|
GOV
2743
DELISTED
Government Properties Income Trust
GOV
| $919K | ﹤0.01% |
49,529
-60,330
| -55% | -$1.23M |
|
|
HCOM
2744
DELISTED
Hawaiian Telcom Holdco, Inc
HCOM
| $918K | ﹤0.01% |
35,186
+2,153
| +7% | +$56.3K |
|
2745
Graham Corp
GHM
$1.09B
| $916K | ﹤0.01% |
44,713
-2,754
| -6% | -$62.1K |
|
2746
PUT
Liberty Global Class C
LBTYK
$3.58B
| $916K | ﹤0.01% |
22,373
| – | – |
|
2747
Royal Caribbean
RCL
$78.2B
| $913K | ﹤0.01% |
+11,658
| New | +$888K |
|
2748
CALL
Qualys
QLYS
$6.09B
| $912K | ﹤0.01% |
+22,600
| New | +$1.01M |
|
2749
Mine Safety
MSA
$7.24B
| $910K | ﹤0.01% |
18,765
-23,780
| -56% | -$1.14M |
|
|
SSI
2750
DELISTED
Stage Stores Inc
SSI
| $909K | ﹤0.01% |
51,846
-249,819
| -83% | -$4.73M |
|
Similar funds
David Shaw's Q2 2015 Portfolio in Review
As of Q2 2015, David Shaw held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw's Q2 2015 filing shows 504 new, 1,541 increased, 1,229 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
- David Shaw's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- David Shaw added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- David Shaw's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- David Shaw fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- David Shaw's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- David Shaw opened 504 new positions and closed 364 in Q2 2015.
- David Shaw's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.